Sign in

NCT06018415Completed

Effects of Early and Late Time-restricted Eating on Overweight Adults With Metabolic Syndrome

Source: ClinicalTrials.gov · Last updated 22 Dec 2025

Brief summary (registry, in English)

Investigators aim to compare the effects of early and late time-restricted feeding on overweight adults with metabolic syndrome

Status (registry)
Completed
Study type
Interventional
Enrollment
103 (actual)
First submitted
13 Aug 2023
Start date
7 May 2024
Primary completion date
16 Oct 2024
Lead sponsor
First Affiliated Hospital Xi'an Jiaotong University
Diseases
Obesity
NCT number
NCT06018415

What you commit to

  • Study type: Interventional
  • Participants enrolled: 103
  • From 7 May 2024 to the primary completion date, 16 Oct 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Unstable weight (change \> 10% current body weight) for 3 months prior to the study
  • Being treated with antibiotics or corticosteroids

Other illness

  • History of major diseases or related diseases, such as cancer, inflammatory disease, chronic obstructive pulmonary disease and major adverse cardiovascular event
  • Active viral hepatitis, acquired immune deficiency syndrome, syphilis and other sexually transmitted diseases, tuberculosis and other infectious diseases
  • Current participate in other weight-management program, current on a prescribed diet for special disease or current on any drugs that effect appetite

Other

  • Pregnant or breast-feeding
  • Night shift workers
  • The researcher deemed it inappropriate to participate in the experimenter.

Who the study is looking for

  • Age from 18 to 65 years
  • Body mass index (BMI): 24.0-40.0 kg/m2
  • Diagnosed with metabolic syndrome (i.e., more than 3 abnormal findings out of 5):
    • Waist circumference ≥ 90 cm (men) or ≥ 80 cm (women).
    • Elevated triglyceride (TG) (use of lipid-lowering medication is an alternate indicator) ≥ 150 mg/dL (1.7 mmol/L).
    • Reduced high-density lipoprotein cholesterol (HDL-c) (use of lipid-lowering medication is an alternate indicator) \< 40 mg/dL (1.0 mmol/L) in males \< 50 mg/dL (1.3 mmol/L) in females.
    • Elevated blood pressure (use of antihypertensive medication is an alternate indicator). Systolic blood pressure (SBP) ≥ 130 and/or diastolic blood pressure (DBP) ≥ 85 mmHg.
    • Elevated fasting blood glucose (FBG) (used of hypoglycemic medications is an alternate indicator) ≥ 100 mg/dL (5.6 mmol/L).

Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
First Affiliated Hospital of Xi'an Jiaotong University
Coordinator of this site? Confirm its status
Xi'anChinaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.